You are here

  • Home
  • Archive
  • Volume 10, Issue 7
  • T cell responses against SARS-CoV-2 and its Omicron variant in a patient with B cell lymphoma after multiple doses of a COVID-19 mRNA vaccine

Article metrics

Article menu
Case report
T cell responses against SARS-CoV-2 and its Omicron variant in a patient with B cell lymphoma after multiple doses of a COVID-19 mRNA vaccine

 

Online download statistics by month:

Online download statistics by month: July 2022 to February 2026

AbstractFullPdf
Jul 2022421426109
Aug 202231331568
Sep 202227928238
Oct 202223924037
Nov 202221121124
Dec 202221121128
Jan 202315715818
Feb 202311711940
Mar 202314915022
Apr 202310210219
May 202313213310
Jun 2023808012
Jul 2023747416
Aug 202376768
Sep 2023676716
Oct 2023626212
Nov 202311611610
Dec 2023626319
Jan 2024262612
Feb 2024333311
Mar 2024747541
Apr 2024747318
May 2024697212
Jun 2024626212
Jul 2024515113
Aug 2024393911
Sep 2024393915
Oct 2024444413
Nov 202439408
Dec 202444457
Jan 202550506
Feb 2025989823
Mar 2025555510
Apr 2025858520
May 2025323213
Jun 2025282812
Jul 2025110
Aug 2025110
Feb 2026110
Total38133835763